Cardiff

ECMC Cardiff

Cardiff ECMC aims to develop biomarkers, novel therapeutic approaches to cancer treatment and expand tissue banking. The Centre has a particular focus on acute myeloid leukaemia (AML) and conducts pre-clinical testing of novel agents that could lead to new treatments for the disease. Another focus area is translating knowledge of molecular pathways into biomarkers for breast cancer.

Research Areas

Focus

Haematological oncology, pathology, tissue resources

Disease Area

Breast, colon, rectal, leukaemia, prostate, thyroid

Goals

Goals

For further information on the goals and objectives of Cardiff ECMC go to:

More about Goals

Skills

Skills

Cardiff ECMC principal investigators and staff have a diverse range of skills and expertise.

More about Skills

Facilities

Facilities

Cardiff ECMC has access to a range of research facilities that are utilised in studies.

More about Facilities

Achievements

Achievements

Patient accrual to clinical trials and activity in early phase studies has increased significantly at Cardiff ECMC.

More Achievements

Centre Lead

Centre Lead

Alan K Burnett

Other key personnel

General and Patient Enquiries

Sian Edwards
Room 162, 7th Floor, A-B Block
Department of Haematology
School of Medicine
Cardiff University
Heath Park
Cardiff
CF14 4XN
Tel: +44 (0) 29 2074 2375

Clinical Trial Information

You can also find out about trials recruiting in Cardiff on the CancerHelp UK clinical trials database.